Literature DB >> 16617303

Sequence variations in the 5' upstream regions of the FBN1 gene associated with Marfan syndrome.

Krishna Kumar Singh1, Praphulla Chandra Shukla, Kathrin Rommel, Jörg Schmidtke, Mine Arslan-Kirchner.   

Abstract

Marfan syndrome (MFS; OMIM#154700) is a connective tissue disorder characterized by manifestations in the ocular, skeletal and cardiovascular systems. MFS is caused by mutation in the fibrillin-1 gene (FBN1; OMIM#134797) and more than 550 mutations have been identified so far. FBN1 is approximately 230 kb in size and contains three evolutionarily conserved alternatively spliced exons B, A and C at the 5'end. In a first systematic attempt to associate sequence variations in the FBN1 5' alternatively spliced exons with MFS, we investigated 41 individuals fulfilling the diagnostic criteria of Ghent nosology or with features of MFS including at least one major criterion or involvement of two organ systems but not fulfilling a strict interpretation of the Ghent nosology, and known to be negative for mutations in the FBN1 exons 1-65 as well as the TGFBR2 and TGFBR1 coding regions. We identified five novel and one previously reported variants in the six unrelated probands and provide preliminary evidence for their role in pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16617303     DOI: 10.1038/sj.ejhg.5201620

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  2 in total

1.  Clinical utility gene card for: Marfan syndrome type 1 and related phenotypes [FBN1].

Authors:  Mine Arslan-Kirchner; Eloisa Arbustini; Catherine Boileau; Anne Child; Gwenaelle Collod-Beroud; Anne De Paepe; Jörg Epplen; Guillaume Jondeau; Bart Loeys; Laurence Faivre
Journal:  Eur J Hum Genet       Date:  2010-04-07       Impact factor: 4.246

2.  TGFBR3 variation is not a common cause of Marfan-like syndrome and Loeys-Dietz-like syndrome.

Authors:  Krishna K Singh; Joerg Schmidtke; Britta Keyser; Mine Arslan-Kirchner
Journal:  J Negat Results Biomed       Date:  2012-02-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.